MedTrace Logo

Assessing the Feasibility, Acceptability and Effects Of HIV Birth Testing In Maternity Settings In Zimbabwe

NCT04206241 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 278833

Last updated 2021-08-18

No results posted yet for this study

Summary

This study aims to assess the feasibility and, acceptability and effects of implementing HIV testing at birth testing using point-of-care (POC) HIV nucleic acid testing (NAT) in maternity settings.

Conditions

  • HIV/AIDS
  • Infant Morbidity
  • Perinatal HIV Infection
  • HIV Infections

Interventions

DIAGNOSTIC_TEST

Point of care early infant diagnosis (POC EID)

HIV testing where the blood sample is processed at either the facility itself or a nearby site that is closer to the facility than a laboratory. With POC EID, blood samples do not have to travel to the laboratory for processing.

Sponsors & Collaborators

  • UNITAID

    collaborator OTHER

  • Elizabeth Glaser Pediatric AIDS Foundation

    lead OTHER

Principal Investigators

  • Agnes Mahomva, MBCHB, MPH · Elizabeth Glaser Pediatric AIDS Foundation - Zimbabwe

Eligibility

Max Age
48 Hours
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-11-01
Completion
2019-12-31

Countries

  • Zimbabwe

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04206241 on ClinicalTrials.gov